full text.pdf Cancer Surgeons’ Distress and Well-being, I: The Tension Between a Culture of Productivity and the Need for Self-Care

WORD on Cancer Team

Word Team

• Nate Manahan
• Dr. Kelly Manahan
• Dr. John Geisler
• Chad Braham
• Steve Younce
• Bill Stacey

he role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: Survey results from members of the SGO (Society of Gynecologic Oncologists)

Society of Gynecologic Oncologists Releases 'Gynecologic Oncology 2010: State of the Subspecialty' Survey Results -- CHICAGO, May 18 /PRNewswire-USNewswire/ --

Highlights from the survey include:

• A movement in the profession to younger-aged practitioners and a larger number of women entering the specialty;
• A shift away from private practice as the primary practice setting into salaried positions and an increase in group or multi-specialty practice from individual practice;
• An increase in the number of medical assistants, nurse practitioners and physician assistants employed in gynecologic oncology practices;
• A continued dedication to providing chemotherapy services to patients regardless of the changes in reimbursement rates, as well as the continuation of enrollment of patients into cooperative studies versus the more revenue neutral or positive industry-sponsored trials;
• The positive effect of caps on non-economic and total damages on the cost of medical liability/malpractice insurance; and the
• An overall willingness of gynecologic oncologists to accept/treat women with a gynecologic cancer without knowledge of insurance coverage and the preponderance of Medicare and Medicaid patients seen in a practice, versus private insurance.

Majority of Medical Oncologists and Ob-Gyns Disagree With New Mammogram Recommendations, New Infogroup's ORC Oncology Report Indicates

The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review

Centre for Review and Dissemination - Database of Abstracts of Reviews of Effects (DARE)

Authors' objectives:
To determine the efficacy of specialised care for patients with ovarian cancer.
Authors' conclusions:The outcome of ovarian cancer was better when treatment was provided in specialised settings (gynecologic oncologists or in specialised hospitals) than that provided in non-specialised settings.

CRD commentary:
"Given the limitations and the lack of reported methodology in the review process, although the results appeared promising the authors conclusion appears to be overstated."

Maurie Markman, MD, explains his passion for gynecologic cancer research | HemOncToday

excerpts from article:

"What is the best advice you’ve ever received?

My earliest mentor was my family physician/internist, who, unfortunately, died of pancreatic cancer many years ago. His advice was to make sure I approached the practice of medicine as a people’s doctor. There is nothing more rewarding than that. I took his advice very seriously and I certainly agree with it.

What would you consider one of your biggest successes in your specialty?

I’ve been involved in the development of a number of strategies, including the development of intraperitoneal therapy in ovarian cancer. However, I would argue the most important thing, which I think and hope I’ve done and continue to do, is to insist upon — for myself and others — viewing and thinking critically about everything we do as physicians. It’s crucial that we absolutely strive for and base our decisions on, as much as possible, solid, evidence-based medicine and phase-3, randomized trials. I believe to my core that the future of medicine has to be evidence-based?"

Mental health and occupational wellbeing of Australian gynaecologic oncologists

Conclusion:"Australian gynaecologic oncologists experience considerable occupational distress while possessing high levels of personal accomplishment and job satisfaction. To maintain a healthy workforce, it is important to build on existing supports while conducting further research to identify suitable evidence-based strategies for improving the mental health of these surgeons."

Quality of care in advanced ovarian cancer: The importance of provider specialty.

BACKGROUND: One of the cornerstones of ovarian cancer therapy is cytoreductive surgery, which can be performed by surgeons with different specialty training. We examined whether surgeon specialty impacts quality of life (as proxied by presence of ostomy) and overall survival for women with advanced ovarian cancer.

Vesna Kesic: exporting excellence in women’s cancers - Cover Story - Cancer World

2009 Newsletter fall issue: GOC (THE SOCIETY OF GYNECOLOGIC ONCOLOGY, LA SOCIÉTÉ DE GYNÉCO-ONCOLOGIE DU CANADA)